Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH, USA.
Wake Forest Innovations, Wake Forest University Health Sciences, Winston-Salem, NC, USA.
Stress. 2021 Mar;24(2):196-205. doi: 10.1080/10253890.2021.1887849. Epub 2021 Mar 17.
Pituitary adenylate cyclase-activating polypeptide (PACAP) is an excitatory neuromodulatory peptide strongly implicated in nervous stress processing. Human polymorphism of the primary PACAP receptor (PAC1) is linked to psychiatric disorders, including posttraumatic stress disorder (PTSD). Prefrontal cortex PACAP signaling is associated with processing of traumatic stress and fear learning, suggesting a potential role in PTSD-related deficits. We used RNAscope to define the cellular location of PACAP and PAC1 in the infralimbic cortex (IL). Subsequent experiments used a pharmacological approach to assess the impact of IL PACAP infusion on behavioral and physiological stress response and fear memory. Adult male Sprague-Dawley rats were bilaterally microinjected with PACAP (1 ug) or vehicle into the IL, 30 minutes prior to forced swim test (FST). Blood was sampled at 15, 30, 60, and 120 minutes for analysis of hypothalamic pituitary adrenal (HPA) axis reactivity. Five days after, animals were tested in a 3-day passive avoidance paradigm with subsequent testing of fear retention two weeks later. We observed that PACAP is highly expressed in putative pyramidal neurons (identified by VGlut1 expression), while PAC1 is enriched in interneurons (identified by GAD). Pretreatment with PACAP increased active coping style in the FST, despite higher levels of ACTH and corticosterone. The treatment was also sufficient to cause an increase in anxiety-like behavior in a dark/light crossover test and enhanced retention of passive avoidance. Our data suggest that IL PACAP plays a role in driving stress responses and in processing of fear memories, likely mediated by inhibition of cortical drive.
垂体腺苷酸环化酶激活肽 (PACAP) 是一种兴奋性神经调质肽,强烈参与神经应激处理。人类主要 PACAP 受体 (PAC1) 的多态性与包括创伤后应激障碍 (PTSD) 在内的精神疾病有关。前额皮质 PACAP 信号与创伤性应激和恐惧学习的处理有关,表明其在 PTSD 相关缺陷中具有潜在作用。我们使用 RNAscope 定义了内侧前额皮质 (IL) 中 PACAP 和 PAC1 的细胞位置。随后的实验使用药理学方法评估 IL PACAP 输注对行为和生理应激反应以及恐惧记忆的影响。成年雄性 Sprague-Dawley 大鼠双侧 IL 内注射 PACAP(1μg)或载体,在强迫游泳试验 (FST) 前 30 分钟。在分析下丘脑-垂体-肾上腺 (HPA) 轴反应性时,在 15、30、60 和 120 分钟时采集血液样本。五天后,动物在为期三天的被动回避范式中进行测试,随后在两周后进行恐惧记忆保留测试。我们观察到 PACAP 在推定的锥体神经元(通过 VGlut1 表达鉴定)中高度表达,而 PAC1 在中间神经元(通过 GAD 鉴定)中富集。PACAP 预处理可增加 FST 中的主动应对方式,尽管 ACTH 和皮质酮水平较高。该治疗还足以引起暗/亮交叉测试中的焦虑样行为增加,并增强被动回避的保留。我们的数据表明,IL PACAP 在驱动应激反应和处理恐惧记忆中起作用,可能通过抑制皮质驱动来介导。